Brightfield Group | ECRM: CBD: FDA Impact & the Path Forward 8/16/2022
2022 Mid-Year US CBD Report
As the CBD industry moves forward without much-needed federal guidance, this year we've forecasted for two scenarios - with and without FDA regulation. This report will help you prepare for either eventuality while adding insights into top performers and key distribution channels.
- What's the projected revenue of the CBD market through 2027?
- What is the forecasted impact of federal regulation?
- Which brands are on top?
- Which industry leaders are growing the fastest?
- Which brands perform best in brick-and-mortar stores vs. online?
- How the grocery channel is responding to risk, and which product types are pulling ahead as a result?
- And much more
Click here to download the report.